GLP-compliant studies using animal models to evaluate the carcinogenic potential of pharmaceuticals, although expensive and time-consuming, are a required element of the overall safety assessment of many new drug candidates.
Conventional carcinogenicity studies are 2-year rodent studies, where the animals are followed over a significant portion of their lifespan for the development of neoplastic lesions during or after exposure to the test article. However, there is growing acceptance of newer, 6-month mouse models that use fewer animals and are less costly. IITRI offers both the conventional 2-year and the more economical 6-month transgenic mouse study options.
- Standard studies using standard bred mice and rats (Sprague Dawley and Fischer 344 rats, CD-1 mice)
- Transgenic mouse model studies (rasH2 or p53+/- knockout mice)
- Studies using inhalation as route of exposure
The IITRI Advantage
- Highly experienced and tenured scientific staff providing you with a seasoned and stable project team for the duration of your study
- Technical advisory and support regarding interpretation of study results
- Board-certified toxicology, pathology, and veterinary staff
- Over 20 years of experience performing carcinogenicity studies
- On-site pathology services
- Access to a large historical control database
Contact Us for more information on our carcinogenicity studies.